{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T02:33:58Z","timestamp":1789439638096,"version":"build-2803163510"},"reference-count":233,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,5,20]],"date-time":"2021-05-20T00:00:00Z","timestamp":1621468800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["RD16\/0017\/0,014"],"award-info":[{"award-number":["RD16\/0017\/0,014"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016658","name":"Plan Nacional Sobre Drogas","doi-asserted-by":"publisher","award":["2019I012"],"award-info":[{"award-number":["2019I012"]}],"id":[{"id":"10.13039\/100016658","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p>Drug treatments available for the management of substance use disorders (SUD) present multiple limitations in efficacy, lack of approved treatments or alarming relapse rates. These facts hamper the clinical outcome and the quality of life of the patients supporting the importance to develop new pharmacological agents. Lately, several reports suggest that cannabidiol (CBD) presents beneficial effects relevant for the management of neurological disorders such as epilepsy, multiple sclerosis, Parkinson\u2019s, or Alzheimer\u2019s diseases. Furthermore, there is a large body of evidence pointing out that CBD improves cognition, neurogenesis and presents anxiolytic, antidepressant, antipsychotic, and neuroprotective effects suggesting potential usefulness for the treatment of neuropsychiatric diseases and SUD. Here we review preclinical and clinical reports regarding the effects of CBD on the regulation of the reinforcing, motivational and withdrawal-related effects of different drugs of abuse such as alcohol, opioids (morphine, heroin), cannabinoids, nicotine, and psychostimulants (cocaine, amphetamine). Furthermore, a special section of the review is focused on the neurobiological mechanisms that might be underlying the \u2018anti-addictive\u2019 action of CBD through the regulation of dopaminergic, opioidergic, serotonergic, and endocannabinoid systems as well as hippocampal neurogenesis. The multimodal pharmacological profile described for CBD and the specific regulation of addictive behavior-related targets explains, at least in part, its therapeutic effects on the regulation of the reinforcing and motivational properties of different drugs of abuse. Moreover, the remarkable safety profile of CBD, its lack of reinforcing properties and the existence of approved medications containing this compound (Sativex\u00ae, Epidiolex\u00ae) increased the number of studies suggesting the potential of CBD as a therapeutic intervention for SUD. The rising number of publications with substantial results on the valuable therapeutic innovation of CBD for treating SUD, the undeniable need of new therapeutic agents to improve the clinical outcome of patients with SUD, and the upcoming clinical trials involving CBD endorse the relevance of this review.<\/jats:p>","DOI":"10.3389\/fphar.2021.626010","type":"journal-article","created":{"date-parts":[[2021,5,20]],"date-time":"2021-05-20T05:52:05Z","timestamp":1621489925000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":64,"title":["Role of Cannabidiol in the Therapeutic Intervention for Substance Use Disorders"],"prefix":"10.3389","volume":"12","author":[{"given":"Francisco","family":"Navarrete","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Salud","family":"Garc\u00eda-Guti\u00e9rrez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ani","family":"Gasparyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amaya","family":"Austrich-Olivares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge","family":"Manzanares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,5,20]]},"reference":[{"key":"B1","first-page":"705","article-title":"Marihuana: Harvey Lecture, February 19, 1942","volume":"18","author":"Adams","year":"1942","journal-title":"Bull. N. Y Acad. Med."},{"key":"B2","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1001\/jamapsychiatry.2013.3947","article-title":"Nabiximols as an Agonist Replacement Therapy during Cannabis Withdrawal","volume":"71","author":"Allsop","year":"2014","journal-title":"JAMA psychiatry"},{"key":"B3","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1002\/cpt.109","article-title":"Cannabinoid Replacement Therapy (CRT): Nabiximols (Sativex) as a Novel Treatment for Cannabis Withdrawal","volume":"97","author":"Allsop","year":"2015","journal-title":"Clin. Pharmacol. Ther."},{"key":"B4","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.addbeh.2018.11.008","article-title":"Relapse after Inpatient Substance Use Treatment: A Prospective Cohort Study Among Users of Illicit Substances","volume":"90","author":"Andersson","year":"2019","journal-title":"Addict. Behaviors"},{"key":"B5","doi-asserted-by":"publisher","first-page":"19","DOI":"10.3389\/fpls.2016.00019","article-title":"Cannabis Sativa: The Plant of the Thousand and One Molecules","volume":"7","author":"Andre","year":"2016","journal-title":"Front. Plant Sci."},{"key":"B6","volume-title":"Diagnostic and Statistical Manual of Mental Disorders","year":"2013"},{"key":"B7","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1111\/j.1369-1600.2011.00406.x","article-title":"Pregabalin and Topiramate Regulate Behavioural and Brain Gene Transcription Changes Induced by Spontaneous Cannabinoid Withdrawal in Mice","volume":"18","author":"Aracil-Fern\u00e1ndez","year":"2013","journal-title":"Addict. Biol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"5382","DOI":"10.1007\/s12035-018-1456-3","article-title":"Adenosine A2A-Cannabinoid CB1 Receptor Heteromers in the Hippocampus: Cannabidiol Blunts \u03949-Tetrahydrocannabinol-Induced Cognitive Impairment","volume":"56","author":"Aso","year":"2019","journal-title":"Mol. Neurobiol."},{"key":"B9","first-page":"37","article-title":"Cannabinoids and the Brain: The Effects of Endogenous and Exogenous Cannabinoids on Brain Systems and Function","volume-title":"Cannabinoids and the Brain: The Effects of Endogenous and Exogenous Cannabinoids on Brain Systems and Function, the Complex Connection between Cannabis and Schizophrenia","author":"Atkinson","year":"2018"},{"key":"B10","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.drugalcdep.2016.11.030","article-title":"Oral Cannabidiol Does Not Produce a Signal for Abuse Liability in Frequent Marijuana Smokers","volume":"172","author":"Babalonis","year":"2017","journal-title":"Drug and Alcohol Dependence"},{"key":"B11","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1089\/can.2017.0047","article-title":"Prolonged Cannabidiol Treatment Effects on Hippocampal Subfield Volumes in Current Cannabis Users","volume":"3","author":"Beale","year":"2018","journal-title":"Cannabis Cannabinoid Res."},{"key":"B12","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1002\/jnr.23963","article-title":"Sex Differences, Gender and Addiction","volume":"95","author":"Becker","year":"2017","journal-title":"J. Neurosci. Res."},{"key":"B13","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1111\/bcp.12051","article-title":"Pharmacological Maintenance Treatments of Opiate Addiction","volume":"77","author":"Bell","year":"2014","journal-title":"Br. J. Clin. Pharmacol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"237","DOI":"10.2174\/157488611798280924","article-title":"Safety and Side Effects of Cannabidiol, a Cannabis Sativa Constituent","volume":"6","author":"Bergamaschi","year":"2011","journal-title":"Curr. Drug Saf."},{"key":"B15","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1186\/s12888-018-1682-2","article-title":"Replacement for Cannabis Dependence Study, Randomised Controlled Trial (RCT) of Cannabinoid Replacement Therapy (Nabiximols) for the Management of Treatment-Resistant Cannabis Dependent Patients: a Study Protocol","volume":"18","author":"Bhardwaj","year":"2018","journal-title":"BMC Psychiatry"},{"key":"B16","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1007\/bf00426828","article-title":"Effect of Some Cannabinoids on Naloxone-Precipitated Abstinence in Morphine-dependent Mice","volume":"49","author":"Bhargava","year":"1976","journal-title":"Psychopharmacol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1038\/sj.bjp.0704327","article-title":"Molecular Targets for Cannabidiol and its Synthetic Analogues: Effect on Vanilloid VR1 Receptors and on the Cellular Uptake and Enzymatic Hydrolysis of Anandamide","volume":"134","author":"Bisogno","year":"2001","journal-title":"Br. J. Pharmacol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1007\/s13311-015-0387-1","article-title":"Cannabidiol as a Potential Treatment for Anxiety Disorders","volume":"12","author":"Blessing","year":"2015","journal-title":"Neurotherapeutics"},{"key":"B19","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1038\/npp.2017.212","article-title":"The Current State of Pharmacological Treatments for Cannabis Use Disorder and Withdrawal","volume":"43","author":"Brezing","year":"2018","journal-title":"Neuropsychopharmacol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1097\/01.yco.0000218592.00689.e5","article-title":"The Cannabis Withdrawal Syndrome","volume":"19","author":"Budney","year":"2006","journal-title":"Curr. Opin. Psychiatry"},{"key":"B21","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.drugalcdep.2006.04.014","article-title":"Oral Delta-9-Tetrahydrocannabinol Suppresses Cannabis Withdrawal Symptoms","volume":"86","author":"Budney","year":"2007","journal-title":"Drug and Alcohol Dependence"},{"key":"B22","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1111\/add.12834","article-title":"A Longitudinal Comparison of Retention in Buprenorphine and Methadone Treatment for Opioid Dependence in New South Wales, Australia","volume":"110","author":"Burns","year":"2015","journal-title":"Addiction"},{"key":"B23","doi-asserted-by":"publisher","first-page":"269881120965952","DOI":"10.1177\/0269881120965952","article-title":"Cannabidiol Prevents Priming- and Stress-Induced Reinstatement of the Conditioned Place Preference Induced by Cocaine in Mice","volume":"9","author":"Calpe-Lopez","year":"2020","journal-title":"J. Psychopharmacol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"73","DOI":"10.3389\/fnbeh.2012.00073","article-title":"The Endocannabinoid System: a Key Modulator of Emotions and Cognition","volume":"6","author":"Campolongo","year":"2012","journal-title":"Front. Behav. Neurosci."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1016\/j.jpsychires.2012.08.012","article-title":"Cannabidiol Blocks Long-Lasting Behavioral Consequences of Predator Threat Stress: Possible Involvement of 5HT1A Receptors","volume":"46","author":"Campos","year":"2012","journal-title":"J. Psychiatr. Res."},{"key":"B25","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1007\/s00213-008-1168-x","article-title":"Involvement of 5HT1A Receptors in the Anxiolytic-like Effects of Cannabidiol Injected into the Dorsolateral Periaqueductal Gray of Rats","volume":"199","author":"Campos","year":"2008","journal-title":"Psychopharmacol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1017\/s1461145712001502","article-title":"The Anxiolytic Effect of Cannabidiol on Chronically Stressed Mice Depends on Hippocampal Neurogenesis: Involvement of the Endocannabinoid System","volume":"16","author":"Campos","year":"2013","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1007\/s00406-007-0730-6","article-title":"Adult Neurogenesis and the Memories of Drug Addiction","volume":"257","author":"Canales","year":"2007","journal-title":"Eur. Arch. Psychiatry Clin. Neurosc."},{"key":"B29","doi-asserted-by":"publisher","first-page":"417S","DOI":"10.1002\/j.1552-4604.1981.tb02622.x","article-title":"Hypnotic and Antiepileptic Effects of Cannabidiol","volume":"21","author":"Carlini","year":"1981","journal-title":"J. Clin. Pharmacol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"7895","DOI":"10.1073\/pnas.0511232103","article-title":"Inhibition of an Equilibrative Nucleoside Transporter by Cannabidiol: a Mechanism of Cannabinoid Immunosuppression","volume":"103","author":"Carrier","year":"2006","journal-title":"Proc. Natl. Acad. Sci."},{"key":"B31","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.neubiorev.2016.03.030","article-title":"A Place for the hippocampus in the Cocaine Addiction Circuit: Potential Roles for Adult Hippocampal Neurogenesis","volume":"66","author":"Castilla-Ortega","year":"2016","journal-title":"Neurosci. Biobehavioral Rev."},{"key":"B32","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1177\/0269881114550355","article-title":"Effects of Cannabidiol in the Treatment of Patients with Parkinson's Disease: an Exploratory Double-Blind Trial","volume":"28","author":"Chagas","year":"2014","journal-title":"J. Psychopharmacol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.drugalcdep.2012.12.005","article-title":"Adult Hippocampal Neurogenesis in the Pathogenesis of Addiction and Dual Diagnosis Disorders","volume":"130","author":"Chambers","year":"2013","journal-title":"Drug and Alcohol Dependence"},{"key":"B34","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s00406-019-00983-5","article-title":"New Trends in Cannabis Potency in United States and Europe during the Last Decade (2008-2017)","volume":"269","author":"Chandra","year":"2019","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"key":"B35","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.3233\/jad-140921","article-title":"Long-term Cannabidiol Treatment Prevents the Development of Social Recognition Memory Deficits in Alzheimer's Disease Transgenic Mice","volume":"42","author":"Cheng","year":"2014","journal-title":"Jad"},{"key":"B36","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/0091-3057(85)90122-4","article-title":"The Quasi-Morphine Withdrawal Syndrome: Effect of Cannabinol, Cannabidiol and Tetrahydrocannabinol","volume":"23","author":"Chesher","year":"1985","journal-title":"Pharmacol. Biochem. Behav."},{"key":"B37","doi-asserted-by":"publisher","first-page":"173065","DOI":"10.1016\/j.pbb.2020.173065","article-title":"Cannabidiol (CBD) Reduces Cocaine-Environment Memory in Mice","volume":"199","author":"Chesworth","year":"2020","journal-title":"Pharmacol. Biochem. Behav."},{"key":"B38","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.addbeh.2017.05.030","article-title":"Increased Use of Heroin as an Initiating Opioid of Abuse","volume":"74","author":"Cicero","year":"2017","journal-title":"Addict. Behaviors"},{"key":"B39","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1016\/S0140-6736(18)31310-2","article-title":"Alcohol Use and Burden for 195 Countries and Territories, 1990-2016: a Systematic Analysis for the Global Burden of Disease Study 2016","volume":"392","author":"Collaborators","year":"2018","journal-title":"Lancet"},{"key":"B40","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1111\/jcpt.12018","article-title":"Cannabidiol for the Treatment of Cannabis Withdrawal Syndrome: a Case Report","volume":"38","author":"Crippa","year":"2013","journal-title":"J. Clin. Pharm. Ther."},{"key":"B41","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1111\/adb.12366","article-title":"Cannabidiol Disrupts the Reconsolidation of Contextual Drug-Associated Memories in Wistar Rats","volume":"22","author":"de Carvalho","year":"2017","journal-title":"Addict. Biol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"627","DOI":"10.3389\/fphar.2019.00627","article-title":"Therapeutic Prospects of Cannabidiol for Alcohol Use Disorder and Alcohol-Related Damages on the Liver and the Brain","volume":"10","author":"De Ternay","year":"2019","journal-title":"Front. Pharmacol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1016\/s2215-0366(18)30337-7","article-title":"The Global Burden of Disease Attributable to Alcohol and Drug Use in 195 Countries and Territories, 1990-2016: a Systematic Analysis for the Global Burden of Disease Study 2016","volume":"5","author":"Degenhardt","year":"2018","journal-title":"The Lancet Psychiatry"},{"key":"B44","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1038\/s41380-018-0038-0","article-title":"Depleting Adult Dentate Gyrus Neurogenesis Increases Cocaine-Seeking Behavior","volume":"24","author":"Deroche-Gamonet","year":"2019","journal-title":"Mol. Psychiatry"},{"key":"B45","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1111\/epi.12631","article-title":"Cannabidiol: Pharmacology and Potential Therapeutic Role in Epilepsy and Other Neuropsychiatric Disorders","volume":"55","author":"Devinsky","year":"2014","journal-title":"Epilepsia"},{"key":"B46","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/s1474-4422(15)00379-8","article-title":"Cannabidiol in Patients with Treatment-Resistant Epilepsy: an Open-Label Interventional Trial","volume":"15","author":"Devinsky","year":"2016","journal-title":"Lancet Neurol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1111\/j.1755-5949.2010.00135.x","article-title":"Role of Serotonin in Central Dopamine Dysfunction","volume":"16","author":"Di Giovanni","year":"2010","journal-title":"CNS Neurosci. Ther."},{"key":"B48","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1111\/acer.13267","article-title":"Psychiatric, Demographic, and Brain Morphological Predictors of Relapse after Treatment for an Alcohol Use Disorder","volume":"41","author":"Durazzo","year":"2017","journal-title":"Alcohol. Clin. Exp. Res."},{"key":"B49","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1177\/0269881112460109","article-title":"Cannabidiol Inhibits THC-Elicited Paranoid Symptoms and Hippocampal-dependent Memory Impairment","volume":"27","author":"Englund","year":"2013","journal-title":"J. Psychopharmacol."},{"key":"B50","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.alcohol.2017.06.004","article-title":"THC Inhibits the Expression of Ethanol-Induced Locomotor Sensitization in Mice","volume":"65","author":"Filev","year":"2017","journal-title":"Alcohol"},{"key":"B51","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1146\/annurev-psych-010213-115159","article-title":"The Nucleus Accumbens: an Interface between Cognition, Emotion, and Action","volume":"66","author":"Floresco","year":"2015","journal-title":"Annu. Rev. Psychol."},{"key":"B53","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.neuropharm.2018.03.001","article-title":"The Anxiolytic Effects of Cannabidiol in Chronically Stressed Mice Are Mediated by the Endocannabinoid System: Role of Neurogenesis and Dendritic Remodeling","volume":"135","author":"Foga\u00e7a","year":"2018","journal-title":"Neuropharmacol."},{"key":"B52","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1016\/j.euroneuro.2013.10.012","article-title":"Effects of Intra-prelimbic Prefrontal Cortex Injection of Cannabidiol on Anxiety-like Behavior: Involvement of 5HT1A Receptors and Previous Stressful Experience","volume":"24","author":"Foga\u00e7a","year":"2014","journal-title":"Eur. Neuropsychopharmacol."},{"key":"B54","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1016\/j.neubiorev.2019.09.036","article-title":"How Does Cannabidiol (CBD) Influence the Acute Effects of Delta-9-Tetrahydrocannabinol (THC) in Humans? A Systematic Review","volume":"107","author":"Freeman","year":"","journal-title":"Neurosci. Biobehavioral Rev."},{"key":"B55","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1111\/add.14525","article-title":"Increasing Potency and Price of Cannabis in Europe, 2006-16","volume":"114","author":"Freeman","year":"","journal-title":"Addiction"},{"key":"B56","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1016\/S2215-0366(20)30290-X","article-title":"Cannabidiol for the Treatment of Cannabis Use Disorder: a Phase 2a, Double-Blind, Placebo-Controlled, Randomised, Adaptive Bayesian Trial","volume":"7","author":"Freeman","year":"2020","journal-title":"Lancet Psychiatry"},{"key":"B57","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1097\/00001756-199702100-00014","article-title":"Cannabinoids Excite Dopamine Neurons in the Ventral Tegmentum and Substantia Nigra","volume":"8","author":"French","year":"1997","journal-title":"Neuroreport"},{"key":"B58","doi-asserted-by":"publisher","first-page":"107740","DOI":"10.1016\/j.neuropharm.2019.107740","article-title":"Cannabidiol Attenuates the Rewarding Effects of Cocaine in Rats by CB2, 5-HT1A and TRPV1 Receptor Mechanisms","volume":"167","author":"Galaj","year":"2020","journal-title":"Neuropharmacol."},{"key":"B59","doi-asserted-by":"publisher","first-page":"1646","DOI":"10.1021\/ja01062a046","article-title":"Isolation, Structure, and Partial Synthesis of an Active Constituent of Hashish","volume":"86","author":"Gaoni","year":"1964","journal-title":"J. Am. Chem. Soc."},{"key":"B60","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1111\/j.1460-9568.2009.07045.x","article-title":"Impact of Cocaine on Adult Hippocampal Neurogenesis in an Animal Model of Differential Propensity to Drug Abuse","volume":"31","author":"Garc\u00eda-Fuster","year":"2010","journal-title":"Eur. J. Neurosci."},{"key":"B61","article-title":"Cannabidiol and Cannabis Use Disorders","volume-title":"Cannabis Use Disorders","author":"Garc\u00eda-Guti\u00e9rrez","year":"2018"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1007\/s13311-020-00976-6","article-title":"Effects of Cannabidiol on Behavioural and Gene Expression Changes Induced by Spontaneous Cocaine Withdrawal","author":"Gasparyan","year":"2020","journal-title":"Neurotherapeutics"},{"key":"B63","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1016\/S0140-6736(18)32279-7","article-title":"Global, Regional, and National Incidence, Prevalence, and Years Lived with Disability for 354 Diseases and Injuries for 195 Countries and Territories, 1990-2017: a Systematic Analysis for the Global Burden of Disease Study 2017","volume":"392","year":"2018","journal-title":"Lancet"},{"key":"B64","first-page":"4906","article-title":"Purified Cannabidiol, the Main Non-psychotropic Component of Cannabis Sativa, Alone, Counteracts Neuronal Apoptosis in Experimental Multiple Sclerosis","volume":"19","author":"Giacoppo","year":"2015","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"B65","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.msard.2017.06.015","article-title":"Sativex in the Management of Multiple Sclerosis-Related Spasticity: An Overview of the Last Decade of Clinical Evaluation","volume":"17","author":"Giacoppo","year":"2017","journal-title":"Mult. Scler. Relat. Disord."},{"key":"B66","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.neuro.2015.08.007","article-title":"Cannabidiol, a Cannabis Sativa Constituent, Inhibits Cocaine-Induced Seizures in Mice: Possible Role of the mTOR Pathway and Reduction in Glutamate Release","volume":"50","author":"Gobira","year":"2015","journal-title":"Neurotoxicol."},{"key":"B67","doi-asserted-by":"publisher","first-page":"2036","DOI":"10.1038\/s41386-018-0050-8","article-title":"Unique Treatment Potential of Cannabidiol for the Prevention of Relapse to Drug Use: Preclinical Proof of Principle","volume":"43","author":"Gonzalez-Cuevas","year":"2018","journal-title":"Neuropsychopharmacol"},{"key":"B68","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.drugalcdep.2011.11.007","article-title":"Diagnostic Criteria for Cannabis Withdrawal Syndrome","volume":"123","author":"Gorelick","year":"2012","journal-title":"Drug and Alcohol Dependence"},{"key":"B69","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.drugalcdep.2017.02.020","article-title":"A Phase III, Randomized, Multi-Center, Double Blind, Placebo Controlled Study of Safety and Efficacy of Lofexidine for Relief of Symptoms in Individuals Undergoing Inpatient Opioid Withdrawal","volume":"176","author":"Gorodetzky","year":"2017","journal-title":"Drug and Alcohol Dependence"},{"key":"B70","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1001\/jamapsychiatry.2015.0584","article-title":"Epidemiology ofDSM-5Alcohol Use Disorder","volume":"72","author":"Grant","year":"2015","journal-title":"JAMA Psychiatry"},{"key":"B71","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1007\/bf02244012","article-title":"Antianxiety Effect of Cannabidiol in the Elevated Plus-Maze","volume":"100","author":"Guimar\u00e3es","year":"1990","journal-title":"Psychopharmacol."},{"key":"B72","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jsat.2018.04.012","article-title":"Lofexidine versus Diazepam for the Treatment of Opioid Withdrawal Syndrome: A Double-Blind Randomized Clinical Trial in Singapore","volume":"91","author":"Guo","year":"2018","journal-title":"J. Substance Abuse Treat."},{"key":"B73","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1124\/jpet.105.085779","article-title":"Comparison of Cannabidiol, Antioxidants, and Diuretics in Reversing Binge Ethanol-Induced Neurotoxicity","volume":"314","author":"Hamelink","year":"2005","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"B76","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1038\/npp.2013.54","article-title":"Nabilone Decreases Marijuana Withdrawal and a Laboratory Measure of Marijuana Relapse","volume":"38","author":"Haney","year":"2013","journal-title":"Neuropsychopharmacol"},{"key":"B75","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1007\/s00213-007-1020-8","article-title":"Effects of THC and Lofexidine in a Human Laboratory Model of Marijuana Withdrawal and Relapse","volume":"197","author":"Haney","year":"2008","journal-title":"Psychopharmacol."},{"key":"B74","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1038\/sj.npp.1300310","article-title":"Marijuana Withdrawal in Humans: Effects of Oral THC or Divalproex","volume":"29","author":"Haney","year":"2004","journal-title":"Neuropsychopharmacol"},{"key":"B77","doi-asserted-by":"publisher","first-page":"1974","DOI":"10.1038\/npp.2015.367","article-title":"Oral Cannabidiol Does Not Alter the Subjective, Reinforcing or Cardiovascular Effects of Smoked Cannabis","volume":"41","author":"Haney","year":"2016","journal-title":"Neuropsychopharmacol"},{"key":"B78","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1176\/appi.ajp.2015.15070907","article-title":"Prevalence and Correlates of DSM-5 Cannabis Use Disorder, 2012-2013: Findings from the National Epidemiologic Survey on Alcohol and Related Conditions-III","volume":"173","author":"Hasin","year":"2016","journal-title":"Ajp"},{"key":"B79","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1177\/0269881118799954","article-title":"Cannabidiol Treatment Reduces the Motivation to Self-Administer Methamphetamine and Methamphetamine-Primed Relapse in Rats","volume":"32","author":"Hay","year":"2018","journal-title":"J. Psychopharmacol."},{"key":"B80","doi-asserted-by":"publisher","first-page":"a039602","DOI":"10.1101\/cshperspect.a039602","article-title":"Glutamatergic Systems and Memory Mechanisms Underlying Opioid Addiction","volume":"11","author":"Heinsbroek","year":"2020","journal-title":"Cold Spring Harb Perspect. Med."},{"key":"B81","doi-asserted-by":"publisher","first-page":"7568","DOI":"10.1038\/s41598-018-25846-2","article-title":"The Effects of Cannabidiol on Impulsivity and Memory during Abstinence in Cigarette Dependent Smokers","volume":"8","author":"Hindocha","year":"","journal-title":"Sci. Rep."},{"key":"B82","doi-asserted-by":"publisher","first-page":"1696","DOI":"10.1111\/add.14243","article-title":"Cannabidiol Reverses Attentional Bias to Cigarette Cues in a Human Experimental Model of Tobacco Withdrawal","volume":"113","author":"Hindocha","year":"","journal-title":"Addiction"},{"key":"B83","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1016\/0024-3205(75)90435-x","article-title":"Interactions between Cannabidiol and \u03949-THC during Abstinence in Morphine-dependent Rats","volume":"17","author":"Hine","year":"1975","journal-title":"Life Sci."},{"key":"B85","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1097\/hrp.0000000000000052","article-title":"Long-term Course of Opioid Addiction","volume":"23","author":"Hser","year":"2015","journal-title":"Harv. Rev. Psychiatry"},{"key":"B84","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1111\/add.12333","article-title":"Treatment Retention Among Patients Randomized to Buprenorphine\/naloxone Compared to Methadone in a Multi-Site Trial","volume":"109","author":"Hser","year":"2014","journal-title":"Addiction"},{"key":"B86","doi-asserted-by":"publisher","first-page":"8762","DOI":"10.1523\/jneurosci.0708-19.2019","article-title":"Cannabidiol Counteracts the Psychotropic Side-Effects of \u0394-9-Tetrahydrocannabinol in the Ventral Hippocampus through Bidirectional Control of ERK1-2 Phosphorylation","volume":"39","author":"Hudson","year":"2019","journal-title":"J. Neurosci."},{"key":"B87","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1176\/appi.ajp.2019.18101191","article-title":"Cannabidiol for the Reduction of Cue-Induced Craving and Anxiety in Drug-Abstinent Individuals with Heroin Use Disorder: A Double-Blind Randomized Placebo-Controlled Trial","volume":"176","author":"Hurd","year":"2019","journal-title":"Ajp"},{"key":"B88","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1007\/s13311-015-0377-3","article-title":"Molecular Targets of Cannabidiol in Neurological Disorders","volume":"12","author":"Ibeas Bih","year":"2015","journal-title":"Neurotherapeutics"},{"key":"B89","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1089\/can.2016.0034","article-title":"An Update on Safety and Side Effects of Cannabidiol: A Review of Clinical Data and Relevant Animal Studies","volume":"2","author":"Iffland","year":"2017","journal-title":"Cannabis Cannabinoid Res."},{"key":"B90","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.ejpb.2020.06.021","article-title":"Pharmacokinetic Investigation of Synthetic Cannabidiol Oral Formulations in Healthy Volunteers","volume":"154","author":"Izgelov","year":"2020","journal-title":"Eur. J. Pharmaceutics Biopharmaceutics"},{"key":"B91","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1523\/jneurosci.12-02-00483.1992","article-title":"Opioids Excite Dopamine Neurons by Hyperpolarization of Local Interneurons","volume":"12","author":"Johnson","year":"1992","journal-title":"J. Neurosci."},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.3390\/molecules25214930","article-title":"A Critical Review of the Role of the Cannabinoid Compounds Delta(9)-Tetrahydrocannabinol (Delta(9)-THC) and Cannabidiol (CBD) and Their Combination in Multiple Sclerosis Treatment","volume":"25","author":"Jones","year":"2020","journal-title":"Molecules"},{"key":"B94","doi-asserted-by":"publisher","first-page":"e12740","DOI":"10.1111\/adb.12740","article-title":"Cannabidiol Modulates the Expression of Neuroinflammatory Factors in Stress- and Drug-Induced Reinstatement of Methamphetamine in Extinguished Rats","volume":"25","author":"Karimi-Haghighi","year":"2020","journal-title":"Addict. Biol."},{"key":"B93","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/j.pnpbp.2017.08.022","article-title":"Cannabidiol Inhibits Priming-Induced Reinstatement of Methamphetamine in REM Sleep Deprived Rats","volume":"82","author":"Karimi-Haghighi","year":"2018","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"B95","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1007\/s00210-006-0033-x","article-title":"Cannabidiol Is an Allosteric Modulator at Mu- and Delta-Opioid Receptors","volume":"372","author":"Kathmann","year":"2006","journal-title":"Naunyn Schmied Arch. Pharmacol."},{"key":"B96","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1146\/annurev-neuro-062111-150420","article-title":"Multiple Functions of Endocannabinoid Signaling in the Brain","volume":"35","author":"Katona","year":"2012","journal-title":"Annu. Rev. Neurosci."},{"key":"B97","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1111\/j.1369-1600.2012.00483.x","article-title":"Cannabidiol Inhibits the Reward-Facilitating Effect of Morphine: Involvement of 5-HT1Areceptors in the Dorsal Raphe Nucleus","volume":"18","author":"Katsidoni","year":"2013","journal-title":"Addict. Biol."},{"key":"B98","doi-asserted-by":"publisher","first-page":"1660","DOI":"10.1111\/j.1471-4159.2008.05733.x","article-title":"Chronic Voluntary Ethanol Intake Hypersensitizes 5-HT1Aautoreceptors in C57BL\/6J Mice","volume":"107","author":"Kela\u00ef","year":"2008","journal-title":"J. Neurochem."},{"key":"B99","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.jsat.2008.04.001","article-title":"A Quantitative Review of the Ubiquitous Relapse Curve","volume":"36","author":"Kirshenbaum","year":"2009","journal-title":"J. Substance Abuse Treat."},{"key":"B100","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1038\/npp.2009.110","article-title":"Neurocircuitry of Addiction","volume":"35","author":"Koob","year":"2010","journal-title":"Neuropsychopharmacol"},{"key":"B101","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1111\/j.1476-5381.2011.01379.x","article-title":"Cannabidiol Inhibits Pathogenic T Cells, Decreases Spinal Microglial Activation and Ameliorates Multiple Sclerosis-like Disease in C57BL\/6 Mice","volume":"163","author":"Kozela","year":"2011","journal-title":"Br. J. Pharmacol."},{"key":"B102","doi-asserted-by":"publisher","first-page":"116","DOI":"10.5334\/pb.476","article-title":"Behavioral and Cerebral Impairments Associated with Binge Drinking in Youth: A Critical Review","volume":"59","author":"Lannoy","year":"2019","journal-title":"Psychol. Belg."},{"key":"B103","doi-asserted-by":"publisher","first-page":"4790","DOI":"10.1111\/bph.13250","article-title":"Cannabidiol Is a Negative Allosteric Modulator of the Cannabinoid CB1 Receptor","volume":"172","author":"Laprairie","year":"2015","journal-title":"Br. J. Pharmacol."},{"key":"B104","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.drugalcdep.2010.04.010","article-title":"Cannabis Withdrawal Symptoms in Non-treatment-seeking Adult Cannabis Smokers","volume":"111","author":"Levin","year":"2010","journal-title":"Drug and Alcohol Dependence"},{"key":"B106","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1016\/j.biopsych.2015.11.018","article-title":"Therapeutic Potential of Cannabinoids in Psychosis","volume":"79","author":"Leweke","year":"2016","journal-title":"Biol. Psychiatry"},{"key":"B105","doi-asserted-by":"publisher","first-page":"e94","DOI":"10.1038\/tp.2012.15","article-title":"Cannabidiol Enhances Anandamide Signaling and Alleviates Psychotic Symptoms of Schizophrenia","volume":"2","author":"Leweke","year":"2012","journal-title":"Transl Psychiatry"},{"key":"B107","doi-asserted-by":"publisher","first-page":"2263","DOI":"10.1517\/14656566.2014.955469","article-title":"Buprenorphine in the Treatment of Opioid Addiction: Opportunities, Challenges and Strategies","volume":"15","author":"Li","year":"2014","journal-title":"Expert Opin. Pharmacother."},{"key":"B108","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.neuropharm.2015.12.017","article-title":"Cannabidiol Induces Rapid-Acting Antidepressant-like Effects and Enhances Cortical 5-HT\/glutamate Neurotransmission: Role of 5-HT1A Receptors","volume":"103","author":"Linge","year":"2016","journal-title":"Neuropharmacol."},{"key":"B109","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1001\/jamainternmed.2019.1993","article-title":"Replacement for Cannabis Dependence Study, Nabiximols for the Treatment of Cannabis Dependence: A Randomized Clinical Trial","volume":"179","author":"Lintzeris","year":"2019","journal-title":"JAMA Intern. Med."},{"key":"B110","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.pbb.2013.08.013","article-title":"Transdermal Delivery of Cannabidiol Attenuates Binge Alcohol-Induced Neurodegeneration in a Rodent Model of an Alcohol Use Disorder","volume":"111","author":"Liput","year":"2013","journal-title":"Pharmacol. Biochem. Behav."},{"key":"B111","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1038\/sj.npp.1300838","article-title":"Cannabidiol Reverses MK-801-Induced Disruption of Prepulse Inhibition in Mice","volume":"31","author":"Long","year":"2006","journal-title":"Neuropsychopharmacol"},{"key":"B114","doi-asserted-by":"publisher","first-page":"e12778","DOI":"10.1111\/adb.12778","article-title":"The Pharmacological Reduction of Hippocampal Neurogenesis Attenuates the Protective Effects of Cannabidiol on Cocaine Voluntary Intake","volume":"25","author":"Luj\u00e1n","year":"2019","journal-title":"Addict. Biol."},{"key":"B113","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.neuropharm.2018.09.043","article-title":"Repeated Cannabidiol Treatment Reduces Cocaine Intake and Modulates Neural Proliferation and CB1R Expression in the Mouse hippocampus","volume":"143","author":"Luj\u00e1n","year":"2018","journal-title":"Neuropharmacol."},{"key":"B112","doi-asserted-by":"publisher","first-page":"109","DOI":"10.3389\/fnbeh.2020.00109","article-title":"The Pro-neurogenic Effects of Cannabidiol and its Potential Therapeutic Implications in Psychiatric Disorders","volume":"14","author":"Lujan","year":"2020","journal-title":"Front. Behav. Neurosci."},{"key":"B115","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1007\/3-540-26573-2_10","article-title":"Distribution of Cannabinoid Receptors in the Central and Peripheral Nervous System","volume":"168","author":"Mackie","year":"2005","journal-title":"Handb Exp. Pharmacol."},{"key":"B116","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1177\/0269881116667706","article-title":"Effects of an Acute Cannabidiol Treatment on Cocaine Self-Administration and Cue-Induced Cocaine Seeking in Male Rats","volume":"31","author":"Mahmud","year":"2017","journal-title":"J. Psychopharmacol."},{"key":"B117","doi-asserted-by":"publisher","first-page":"823","DOI":"10.15288\/jsa.2006.67.823","article-title":"Drinking in the Year after Treatment as a Predictor of Three-Year Drinking Outcomes","volume":"67","author":"Maisto","year":"2006","journal-title":"J. Stud. Alcohol."},{"key":"B118","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.tins.2006.01.008","article-title":"Involvement of the Endocannabinoid System in Drug Addiction","volume":"29","author":"Maldonado","year":"2006","journal-title":"Trends Neurosciences"},{"key":"B119","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.tins.2011.12.005","article-title":"The Addicted Brain Craves New Neurons: Putative Role for Adult-Born Progenitors in Promoting Recovery","volume":"35","author":"Mandyam","year":"2012","journal-title":"Trends Neurosciences"},{"key":"B120","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.bcp.2018.09.013","article-title":"Role of the Endocannabinoid System in Drug Addiction","volume":"157","author":"Manzanares","year":"2018","journal-title":"Biochem. Pharmacol."},{"key":"B122","doi-asserted-by":"publisher","first-page":"63","DOI":"10.3389\/fnbeh.2011.00063","article-title":"Endocannabinoid System and Psychiatry: in Search of a Neurobiological Basis for Detrimental and Potential Therapeutic Effects","volume":"5","author":"Marco","year":"2011","journal-title":"Front. Behav. Neurosci."},{"key":"B121","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1177\/0269881111408459","article-title":"The Endocannabinoid System in the Regulation of Emotions throughout Lifespan: a Discussion on Therapeutic Perspectives","volume":"26","author":"Marco","year":"2012","journal-title":"J. Psychopharmacol."},{"key":"B123","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1055\/s-0043-117838","article-title":"Effects of Cannabidiol on Morphine Conditioned Place Preference in Mice","volume":"84","author":"Markos","year":"2018","journal-title":"Planta Med."},{"key":"B125","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1124\/mol.111.071290","article-title":"Cannabidiol and Other Cannabinoids Reduce Microglial Activation In Vitro and In Vivo: Relevance to Alzheimer's Disease","volume":"79","author":"Mart\u00edn-Moreno","year":"2011","journal-title":"Mol. Pharmacol."},{"key":"B124","doi-asserted-by":"publisher","first-page":"744","DOI":"10.3389\/fphar.2017.00744","article-title":"Binding and Signaling Studies Disclose a Potential Allosteric Site for Cannabidiol in Cannabinoid CB2 Receptors","volume":"8","author":"Martinez-Pinilla","year":"2017","journal-title":"Front. Pharmacol."},{"key":"B126","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1111\/j.1471-4159.2007.05073.x","article-title":"5-Lipoxygenase and Anandamide Hydrolase (FAAH) Mediate the Antitumor Activity of Cannabidiol, a Non-psychoactive Cannabinoid","volume":"104","author":"Massi","year":"2008","journal-title":"J. Neurochem."},{"key":"B127","doi-asserted-by":"publisher","first-page":"CD002207","DOI":"10.1002\/14651858.CD002207.pub3","article-title":"Buprenorphine Maintenance versus Placebo or Methadone Maintenance for Opioid Dependence","volume":"3","author":"Mattick","year":"2014","journal-title":"Cochrane Database Syst. Rev."},{"key":"B129","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1111\/bph.12944","article-title":"Are Cannabidiol and \u03949-tetrahydrocannabivarin Negative Modulators of the Endocannabinoid System? A Systematic Review","volume":"172","author":"McPartland","year":"2015","journal-title":"Br. J. Pharmacol."},{"key":"B128","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1093\/acprof:oso\/9780199662685.003.0015","article-title":"Non-phytocannabinoid Constituents of Cannabis and Herbal Synergy","volume-title":"Handbook of Cannabis","author":"McPartland","year":"2014"},{"key":"B130","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/0040-4020(63)85022-x","article-title":"The Structure of Cannabidiol","volume":"19","author":"Mechoulam","year":"1963","journal-title":"Tetrahedron"},{"key":"B131","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.3389\/fphar.2018.01365","article-title":"A Systematic Review on the Pharmacokinetics of Cannabidiol in Humans","volume":"9","author":"Millar","year":"2018","journal-title":"Front. Pharmacol."},{"key":"B132","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/978-3-319-45541-9_4","article-title":"Molecular Targets of the Phytocannabinoids: A Complex Picture","volume":"103","author":"Morales","year":"2017","journal-title":"Prog. Chem. Org. Nat. Prod."},{"key":"B134","doi-asserted-by":"publisher","first-page":"1466","DOI":"10.1016\/j.pnpbp.2006.06.004","article-title":"Anxiolytic-like Effect of Cannabidiol in the Rat Vogel Conflict Test","volume":"30","author":"Moreira","year":"2006","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"B133","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.ejphar.2005.02.040","article-title":"Cannabidiol Inhibits the Hyperlocomotion Induced by Psychotomimetic Drugs in Mice","volume":"512","author":"Moreira","year":"2005","journal-title":"Eur. J. Pharmacol."},{"key":"B135","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1192\/bjp.bp.107.046649","article-title":"Effects of Cannabidiol on Schizophrenia-like Symptoms in People Who Use Cannabis","volume":"192","author":"Morgan","year":"2008","journal-title":"Br. J. Psychiatry"},{"key":"B139","doi-asserted-by":"publisher","first-page":"2433","DOI":"10.1016\/j.addbeh.2013.03.011","article-title":"Cannabidiol Reduces Cigarette Consumption in Tobacco Smokers: Preliminary Findings","volume":"38","author":"Morgan","year":"2013","journal-title":"Addict. Behaviors"},{"key":"B138","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1017\/s0033291711001322","article-title":"Sub-chronic Impact of Cannabinoids in Street Cannabis on Cognition, Psychotic-like Symptoms and Psychological Well-Being","volume":"42","author":"Morgan","year":"2012","journal-title":"Psychol. Med."},{"key":"B136","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1192\/bjp.bp.110.077503","article-title":"Impact of Cannabidiol on the Acute Memory and Psychotomimetic Effects of Smoked Cannabis: Naturalistic Study","volume":"197","author":"Morgan","year":"","journal-title":"Br. J. Psychiatry"},{"key":"B137","doi-asserted-by":"publisher","first-page":"1879","DOI":"10.1038\/npp.2010.58","article-title":"Cannabidiol Attenuates the Appetitive Effects of \u03949-Tetrahydrocannabinol in Humans Smoking Their Chosen Cannabis","volume":"35","author":"Morgan","year":"","journal-title":"Neuropsychopharmacol"},{"key":"B141","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.pneurobio.2007.01.001","article-title":"Serotonin and Psychostimulant Addiction: Focus on 5-Ht1a-Receptors","volume":"81","author":"M\u00fcller","year":"2007","journal-title":"Prog. Neurobiol."},{"key":"B140","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.bbr.2014.04.007","article-title":"The Role of Serotonin in Drug Use and Addiction","volume":"277","author":"M\u00fcller","year":"2015","journal-title":"Behav. Brain Res."},{"key":"B142","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1016\/j.lfs.2011.01.013","article-title":"Effects on Sleep and Dopamine Levels of Microdialysis Perfusion of Cannabidiol into the Lateral Hypothalamus of Rats","volume":"88","author":"Murillo-Rodr\u00edguez","year":"2011","journal-title":"Life Sci."},{"key":"B143","doi-asserted-by":"publisher","first-page":"1552","DOI":"10.1111\/bph.14147","article-title":"Single and Combined Effects of Plant-Derived and Synthetic Cannabinoids on Cognition and Cannabinoid-Associated Withdrawal Signs in Mice","volume":"176","author":"Myers","year":"2019","journal-title":"Br. J. Pharmacol."},{"key":"B144","doi-asserted-by":"publisher","first-page":"2676","DOI":"10.1111\/bph.14226","article-title":"Cannabidiol Regulates Behavioural Alterations and Gene Expression Changes Induced by Spontaneous Cannabinoid Withdrawal","volume":"175","author":"Navarrete","year":"2018","journal-title":"Br. J. Pharmacol."},{"key":"B145","doi-asserted-by":"publisher","first-page":"315","DOI":"10.3389\/fpsyt.2020.00315","article-title":"Endocannabinoid System Components as Potential Biomarkers in Psychiatry","volume":"11","author":"Navarrete","year":"2020","journal-title":"Front. Psychiatry"},{"key":"B146","doi-asserted-by":"publisher","first-page":"e12843","DOI":"10.1111\/adb.12843","article-title":"The Loss of NMDAR-dependent LTD Following Cannabinoid Self-Administration Is Restored by Positive Allosteric Modulation of CB1 Receptors","volume":"25","author":"Neuhofer","year":"2019","journal-title":"Addict. Biol."},{"key":"B147","doi-asserted-by":"publisher","first-page":"130","DOI":"10.3389\/fpsyt.2013.00130","article-title":"Does Cannabidiol Protect against Adverse Psychological Effects of THC?","volume":"4","author":"Niesink","year":"2013","journal-title":"Front. Psychiatry"},{"key":"B148","doi-asserted-by":"publisher","first-page":"2839","DOI":"10.1038\/npp.2016.93","article-title":"Cannabidiol Modulates Fear Memory Formation through Interactions with Serotonergic Transmission in the Mesolimbic System","volume":"41","author":"Norris","year":"2016","journal-title":"Neuropsychopharmacol"},{"key":"B149","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1038\/nrn3939","article-title":"The Dopamine Theory of Addiction: 40 Years of Highs and Lows","volume":"16","author":"Nutt","year":"2015","journal-title":"Nat. Rev. Neurosci."},{"key":"B150","volume-title":"Informe sobre la situaci\u00f3n mundial del alcohol y la salud 2018","author":"Oms","year":"2019"},{"key":"B151","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/j.neubiorev.2016.11.012","article-title":"A Systematic Review of the Effect of Cannabidiol on Cognitive Function: Relevance to Schizophrenia","volume":"72","author":"Osborne","year":"2016","journal-title":"Neurosci. biobehavioral Rev."},{"key":"B152","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1007\/s00213-004-1825-7","article-title":"Effect of Low Doses of ?9-tetrahydrocannabinol and Cannabidiol on the Extinction of Cocaine-Induced and Amphetamine-Induced Conditioned Place Preference Learning in Rats","volume":"175","author":"Parker","year":"2004","journal-title":"Psychopharmacol."},{"key":"B153","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1038\/nrn4004","article-title":"Endocannabinoid Signalling in Reward and Addiction","volume":"16","author":"Parsons","year":"2015","journal-title":"Nat. Rev. Neurosci."},{"key":"B154","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1186\/s12913-016-1548-6","article-title":"Improved Drug-Use Patterns at 6 Months Post-discharge from Inpatient Substance Use Disorder Treatment: Results from Compulsorily and Voluntarily Admitted Patients","volume":"16","author":"Pasareanu","year":"2016","journal-title":"BMC Health Serv. Res."},{"key":"B155","volume-title":"Cannabis Use Disorder, StatPearls","author":"Patel","year":"2020"},{"key":"B156","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1136\/jnnp-2015-312591","article-title":"Efficacy and Safety of Cannabinoid Oromucosal Spray for Multiple Sclerosis Spasticity","volume":"87","author":"Patti","year":"2016","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"B157","doi-asserted-by":"publisher","first-page":"303","DOI":"10.3389\/fphar.2016.00303","article-title":"Cannabidiol, Among Other Cannabinoid Drugs, Modulates Prepulse Inhibition of Startle in the SHR Animal Model: Implications for Schizophrenia Pharmacotherapy","volume":"7","author":"Peres","year":"2016","journal-title":"Front. Pharmacol."},{"key":"B158","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1038\/sj.bjp.0707442","article-title":"The Diverse CB1 and CB2 Receptor Pharmacology of Three Plant Cannabinoids: \u03949 -tetrahydrocannabinol, Cannabidiol and \u03949 -tetrahydrocannabivarin","volume":"153","author":"Pertwee","year":"2008","journal-title":"Br. J. Pharmacol."},{"key":"B159","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1007\/s40263-020-00741-5","article-title":"Critical Aspects Affecting Cannabidiol Oral Bioavailability and Metabolic Elimination, and Related Clinical Implications","volume":"34","author":"Perucca","year":"2020","journal-title":"CNS Drugs"},{"key":"B160","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1016\/s0306-4530(01)00088-9","article-title":"Neuroendocrine Evaluation of 5-HT1A Function in Male Alcoholic Patients","volume":"27","author":"Pinto","year":"2002","journal-title":"Psychoneuroendocrinol."},{"key":"B161","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1038\/nrn1247","article-title":"The Molecular Logic of Endocannabinoid Signalling","volume":"4","author":"Piomelli","year":"2003","journal-title":"Nat. Rev. Neurosci."},{"key":"B162","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1007\/s12640-020-00218-9","article-title":"Cannabidiol Prevents the Expression of the Locomotor Sensitization and the Metabolic Changes in the Nucleus Accumbens and Prefrontal Cortex Elicited by the Combined Administration of Cocaine and Caffeine in Rats","volume":"38","author":"Prieto","year":"2020","journal-title":"Neurotox Res."},{"key":"B163","doi-asserted-by":"publisher","first-page":"586110","DOI":"10.3389\/fphar.2020.586110","article-title":"Cannabidiol Treatment for Refractory Epilepsies in Pediatrics","volume":"11","author":"Raucci","year":"2020","journal-title":"Front. Pharmacol."},{"key":"B164","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1097\/fbp.0000000000000544","article-title":"Neuroprotective Effect of Chronic Administration of Cannabidiol during the Abstinence Period on Methamphetamine-Induced Impairment of Recognition Memory in the Rats","volume":"31","author":"Razavi","year":"2020","journal-title":"Behav. Pharmacol."},{"key":"B165","doi-asserted-by":"publisher","first-page":"14764","DOI":"10.1523\/jneurosci.4291-09.2009","article-title":"Cannabidiol, a Nonpsychotropic Component of Cannabis, Inhibits Cue-Induced Heroin Seeking and Normalizes Discrete Mesolimbic Neuronal Disturbances","volume":"29","author":"Ren","year":"2009","journal-title":"J. Neurosci."},{"key":"B166","doi-asserted-by":"publisher","first-page":"5160","DOI":"10.1523\/jneurosci.3387-15.2016","article-title":"Cannabidiol Counteracts Amphetamine-Induced Neuronal and Behavioral Sensitization of the Mesolimbic Dopamine Pathway through a Novel mTOR\/p70S6 Kinase Signaling Pathway","volume":"36","author":"Renard","year":"2016","journal-title":"J. Neurosci."},{"key":"B167","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.bbr.2006.05.016","article-title":"Effects of Cannabidiol and Diazepam on Behavioral and Cardiovascular Responses Induced by Contextual Conditioned Fear in Rats","volume":"172","author":"Resstel","year":"2006","journal-title":"Behav. Brain Res."},{"key":"B168","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1016\/s0024-3205(02)01728-9","article-title":"5-HT1A Receptor Blockade and the Motivational Profile of Ethanol","volume":"71","author":"Risinger","year":"2002","journal-title":"Life Sci."},{"key":"B169","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1517\/14740338.2011.575778","article-title":"Abuse Potential and Psychoactive Effects of \u03b4-9-tetrahydrocannabinol and Cannabidiol Oromucosal Spray (Sativex), a New Cannabinoid Medicine","volume":"10","author":"Robson","year":"2011","journal-title":"Expert Opin. Drug Saf."},{"key":"B170","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1007\/s40263-017-0413-4","article-title":"Binge Drinking: Current Diagnostic and Therapeutic Issues","volume":"31","author":"Rolland","year":"2017","journal-title":"CNS Drugs"},{"key":"B171","doi-asserted-by":"publisher","first-page":"e0234809","DOI":"10.1371\/journal.pone.0234809","article-title":"Treatment of Stimulant Use Disorder: A Systematic Review of Reviews","volume":"15","author":"Ronsley","year":"2020","journal-title":"PLoS One"},{"key":"B172","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.15585\/mmwr.mm655051e1","article-title":"Increases in Drug and Opioid-Involved Overdose Deaths - United States, 2010-2015","volume":"65","author":"Rudd","year":"2016","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"B174","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1007\/s11064-005-6978-1","article-title":"Agonistic Properties of Cannabidiol at 5-HT1a Receptors","volume":"30","author":"Russo","year":"2005","journal-title":"Neurochem. Res."},{"key":"B173","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.mehy.2005.08.026","article-title":"A Tale of Two Cannabinoids: the Therapeutic Rationale for Combining Tetrahydrocannabinol and Cannabidiol","volume":"66","author":"Russo","year":"2006","journal-title":"Med. Hypotheses"},{"key":"B175","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1038\/sj.bjp.0707460","article-title":"The Orphan Receptor GPR55 Is a Novel Cannabinoid Receptor","volume":"152","author":"Ryberg","year":"2007","journal-title":"Br. J. Pharmacol."},{"key":"B176","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1176\/appi.focus.17202","article-title":"Psychosocial and Pharmacological Interventions for the Treatment of Cannabis Use Disorder","volume":"17","author":"Sabioni","year":"2019","journal-title":"Foc"},{"key":"B177","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.bbi.2018.11.003","article-title":"Anti-inflammatory Agents for Smoking Cessation? Focus on Cognitive Deficits Associated with Nicotine Withdrawal in Male Mice","volume":"75","author":"Saravia","year":"2019","journal-title":"Brain Behav. Immun."},{"key":"B178","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.bbr.2016.01.033","article-title":"Antidepressant-like Effect of Cannabidiol Injection into the Ventral Medial Prefrontal Cortex-Possible Involvement of 5-HT1A and CB1 Receptors","volume":"303","author":"Sartim","year":"2016","journal-title":"Behav. Brain Res."},{"key":"B179","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.pnpbp.2015.06.017","article-title":"Influence of Single and Repeated Cannabidiol Administration on Emotional Behavior and Markers of Cell Proliferation and Neurogenesis in Non-stressed Mice","volume":"64","author":"Schiavon","year":"2016","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"B180","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1002\/hup.1196","article-title":"A Randomized, Double-Blind, Placebo-Controlled, Crossover Study to Evaluate the Subjective Abuse Potential and Cognitive Effects of Nabiximols Oromucosal Spray in Subjects with a History of Recreational Cannabis Use","volume":"26","author":"Schoedel","year":"2011","journal-title":"Hum. Psychopharmacol."},{"key":"B181","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.yebeh.2018.07.027","article-title":"Abuse Potential Assessment of Cannabidiol (CBD) in Recreational Polydrug Users: A Randomized, Double-Blind, Controlled Trial","volume":"88","author":"Schoedel","year":"2018","journal-title":"Epilepsy Behav."},{"key":"B182","doi-asserted-by":"publisher","first-page":"e920","DOI":"10.1038\/tp.2016.195","article-title":"Cannabidiol Is a Partial Agonist at Dopamine D2High Receptors, Predicting its Antipsychotic Clinical Dose","volume":"6","author":"Seeman","year":"2016","journal-title":"Transl Psychiatry"},{"key":"B183","doi-asserted-by":"publisher","first-page":"F1000Res","DOI":"10.12688\/f1000research.16515.1","article-title":"Epidiolex as Adjunct Therapy for Treatment of Refractory Epilepsy: a Comprehensive Review with a Focus on Adverse Effects","volume":"8","author":"Sekar","year":"2019","journal-title":"F1000Res"},{"key":"B184","first-page":"31","article-title":"Cannabidiol Oil for Decreasing Addictive Use of Marijuana: A Case Report","volume":"14","author":"Shannon","year":"2015","journal-title":"Integr. Med. (Encinitas)"},{"key":"B185","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.pharmthera.2010.02.004","article-title":"Pharmacological Characterization of GPR55, a Putative Cannabinoid Receptor","volume":"126","author":"Sharir","year":"2010","journal-title":"Pharmacol. Ther."},{"key":"B186","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1007\/s11920-011-0224-0","article-title":"New Findings on Biological Factors Predicting Addiction Relapse Vulnerability","volume":"13","author":"Sinha","year":"2011","journal-title":"Curr. Psychiatry Rep."},{"key":"B187","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.neuropharm.2017.05.031","article-title":"The Endocannabinoid System as a Target for Addiction Treatment: Trials and Tribulations","volume":"124","author":"Sloan","year":"2017","journal-title":"Neuropharmacol."},{"key":"B188","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1038\/bjp.2008.130","article-title":"The Endocannabinoid System in Brain Reward Processes","volume":"154","author":"Solinas","year":"2008","journal-title":"Br. J. Pharmacol."},{"key":"B190","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s00406-019-00978-2","article-title":"A Randomised Controlled Trial of Vaporised \u03949-tetrahydrocannabinol and Cannabidiol Alone and in Combination in Frequent and Infrequent Cannabis Users: Acute Intoxication Effects","volume":"269","author":"Solowij","year":"2019","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"key":"B189","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1089\/can.2017.0043","article-title":"Therapeutic Effects of Prolonged Cannabidiol Treatment on Psychological Symptoms and Cognitive Function in Regular Cannabis Users: A Pragmatic Open-Label Clinical Trial","volume":"3","author":"Solowij","year":"2018","journal-title":"Cannabis Cannabinoid Res."},{"key":"B191","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1080\/14656566.2017.1349098","article-title":"Pharmacotherapy of Alcoholism - an Update on Approved and Off-Label Medications","volume":"18","author":"Soyka","year":"2017","journal-title":"Expert Opin. Pharmacother."},{"key":"B192","doi-asserted-by":"publisher","first-page":"2046","DOI":"10.1073\/pnas.89.6.2046","article-title":"Opposing Tonically Active Endogenous Opioid Systems Modulate the Mesolimbic Dopaminergic Pathway","volume":"89","author":"Spanagel","year":"1992","journal-title":"Proc. Natl. Acad. Sci."},{"key":"B193","doi-asserted-by":"publisher","first-page":"114004","DOI":"10.1016\/j.bcp.2020.114004","article-title":"Altered Dopamine D3 Receptor Gene Expression in MAM Model of Schizophrenia Is Reversed by Peripubertal Cannabidiol Treatment","volume":"177","author":"Stark","year":"2020","journal-title":"Biochem. Pharmacol."},{"key":"B194","volume-title":"National Survey on Drug Use and Health","year":"2016"},{"key":"B195","doi-asserted-by":"publisher","first-page":"11104","DOI":"10.1073\/pnas.0912810107","article-title":"Long-lasting Reduction in Hippocampal Neurogenesis by Alcohol Consumption in Adolescent Nonhuman Primates","volume":"107","author":"Taffe","year":"2010","journal-title":"Proc. Natl. Acad. Sci."},{"key":"B196","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1046\/j.1460-9568.1998.00135.x","article-title":"A Dopamine-\u039c1opioid Link in the Rat Ventral Tegmentum Shared by Palatable Food (Fonzies) and Non-psychostimulant Drugs of Abuse","volume":"10","author":"Tanda","year":"1998","journal-title":"Eur. J. Neurosci."},{"key":"B197","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1007\/s40263-018-0578-5","article-title":"A Phase I, Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose, Multiple Dose, and Food Effect Trial of the Safety, Tolerability and Pharmacokinetics of Highly Purified Cannabidiol in Healthy Subjects","volume":"32","author":"Taylor","year":"2018","journal-title":"CNS Drugs"},{"key":"B198","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1111\/bph.14440","article-title":"Allosteric and Orthosteric Pharmacology of Cannabidiol and Cannabidiol-Dimethylheptyl at the Type 1 and Type 2 Cannabinoid Receptors","volume":"176","author":"Tham","year":"2019","journal-title":"Br. J. Pharmacol."},{"key":"B199","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1038\/sj.bjp.0707133","article-title":"Cannabidiol Displays Unexpectedly High Potency as an Antagonist of CB1 and CB2 Receptor Agonists In Vitro","volume":"150","author":"Thomas","year":"2007","journal-title":"Br. J. Pharmacol."},{"key":"B200","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1038\/mp.2013.57","article-title":"Increasing Dopamine D2 Receptor Expression in the Adult Nucleus Accumbens Enhances Motivation","volume":"18","author":"Trifilieff","year":"2013","journal-title":"Mol. Psychiatry"},{"key":"B203","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/j.drugalcdep.2016.02.020","article-title":"Effects of Fixed or Self-Titrated Dosages of Sativex on Cannabis Withdrawal and Cravings","volume":"161","author":"Trigo","year":"","journal-title":"Drug and Alcohol Dependence"},{"key":"B201","first-page":"187","article-title":"The Role of the Endocannabinoid System in Addiction","volume-title":"The Endocannabinoid System. Genetics, Biochemistry, and Therapy","author":"Trigo","year":"2017"},{"key":"B204","doi-asserted-by":"publisher","first-page":"e0190768","DOI":"10.1371\/journal.pone.0190768","article-title":"Nabiximols Combined with Motivational Enhancement\/cognitive Behavioral Therapy for the Treatment of Cannabis Dependence: A Pilot Randomized Clinical Trial","volume":"13","author":"Trigo","year":"2018","journal-title":"PLoS One"},{"key":"B202","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1097\/adm.0000000000000229","article-title":"Sativex Associated with Behavioral-Relapse Prevention Strategy as Treatment for Cannabis Dependence","volume":"10","author":"Trigo","year":"","journal-title":"J. Addict. Med."},{"key":"B205","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1111\/acer.13964","article-title":"Cannabidiol as a Novel Candidate Alcohol Use Disorder Pharmacotherapy: A Systematic Review","volume":"43","author":"Turna","year":"2019","journal-title":"Alcohol. Clin. Exp. Re"},{"key":"B206","volume-title":"World Drug Report 2019","year":"2019"},{"key":"B207","doi-asserted-by":"publisher","first-page":"466","DOI":"10.3389\/fncel.2014.00466","article-title":"Glutamatergic Synaptic Plasticity in the Mesocorticolimbic System in Addiction","volume":"8","author":"van Huijstee","year":"2014","journal-title":"Front Cel Neurosci"},{"key":"B208","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.drugalcdep.2012.08.001","article-title":"The Dose Effects of Short-Term Dronabinol (Oral THC) Maintenance in Daily Cannabis Users","volume":"128","author":"Vandrey","year":"2013","journal-title":"Drug and Alcohol Dependence"},{"key":"B209","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.drugalcdep.2007.11.017","article-title":"Divergent Effects of Cannabidiol on the Discriminative Stimulus and Place Conditioning Effects of \u03949-tetrahydrocannabinol","volume":"94","author":"Vann","year":"2008","journal-title":"Drug and Alcohol Dependence"},{"key":"B214","doi-asserted-by":"publisher","first-page":"e12765","DOI":"10.1111\/adb.12765","article-title":"Gender Differences in the Effects of Cannabidiol on Ethanol Binge Drinking in Mice","volume":"25","author":"Viudez-Mart\u00ednez","year":"2020","journal-title":"Addict. Biol."},{"key":"B212","doi-asserted-by":"publisher","first-page":"3369","DOI":"10.1111\/bph.14380","article-title":"Effects of Cannabidiol Plus Naltrexone on Motivation and Ethanol Consumption","volume":"175","author":"Viudez-Martinez","year":"","journal-title":"Br. J. Pharmacol."},{"key":"B213","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1038\/s41401-018-0032-8","article-title":"Cannabidiol Does Not Display Drug Abuse Potential in Mice Behavior","volume":"40","author":"Viudez-Mart\u00ednez","year":"2019","journal-title":"Acta Pharmacol. Sin"},{"key":"B210","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1111\/adb.12495","article-title":"Cannabidiol Reduces Ethanol Consumption, Motivation and Relapse in Mice","volume":"23","author":"Viudez-Mart\u00ednez","year":"","journal-title":"Addict. Biol."},{"key":"B215","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1177\/0269881119841568","article-title":"Dissociable Effects of Cannabis with and without Cannabidiol on the Human Brain's Resting-State Functional Connectivity","volume":"33","author":"Wall","year":"2019","journal-title":"J. Psychopharmacol."},{"key":"B216","doi-asserted-by":"publisher","first-page":"12064","DOI":"10.1038\/s41598-017-10924-8","article-title":"Cannabidiol Attenuates Alcohol-Induced Liver Steatosis, Metabolic Dysregulation, Inflammation and Neutrophil-Mediated Injury","volume":"7","author":"Wang","year":"2017","journal-title":"Sci. Rep."},{"key":"B217","volume-title":"Global Status Report on Alcohol and Health","year":"2018"},{"key":"B218","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1038\/nrn1406","article-title":"Dopamine, Learning and Motivation","volume":"5","author":"Wise","year":"2004","journal-title":"Nat. Rev. Neurosci."},{"key":"B219","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1037\/a0022889","article-title":"Predictors of Heavy Drinking during and Following Treatment","volume":"25","author":"Witkiewitz","year":"2011","journal-title":"Psychol. Addict. Behaviors"},{"key":"B220","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/1478-811x-8-12","article-title":"Cannabinoid Receptor CB1 Mediates Baseline and Activity-Induced Survival of New Neurons in Adult Hippocampal Neurogenesis","volume":"8","author":"Wolf","year":"2010","journal-title":"Cell Commun Signal"},{"key":"B221","volume-title":"United Nation Office on Drugs and Crime (UNODC)","year":"2020"},{"key":"B223","volume-title":"International Classification of Diseases for Mortality and Morbidity Statistics (11th Revision)","year":"2018"},{"key":"B222","volume-title":"Tobacco Fact Sheet","year":"2020"},{"key":"B224","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1111\/bph.12199","article-title":"Cannabidiol Attenuates Deficits of Visuospatial Associative Memory Induced by \u03949tetrahydrocannabinol","volume":"170","author":"Wright","year":"2013","journal-title":"Br. J. Pharmacol."},{"key":"B225","doi-asserted-by":"publisher","first-page":"8476","DOI":"10.1523\/jneurosci.1598-11.2011","article-title":"Mesocorticolimbic Glutamatergic Pathway","volume":"31","author":"Yamaguchi","year":"2011","journal-title":"J. Neurosci."},{"key":"B227","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1093\/toxres\/tfaa021","article-title":"Cannabidiol Attenuates Methamphetamine-Induced Conditioned Place Preference via the Sigma1R\/AKT\/GSK-3\u03b2\/CREB Signaling Pathway in Rats","volume":"9","author":"Yang","year":"2020","journal-title":"Toxicol. Res. (Camb)"},{"key":"B226","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.freeradbiomed.2013.12.026","article-title":"Cannabidiol Protects Liver from Binge Alcohol-Induced Steatosis by Mechanisms Including Inhibition of Oxidative Stress and Increase in Autophagy","volume":"68","author":"Yang","year":"2014","journal-title":"Free Radic. Biol. Med."},{"key":"B228","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1038\/npp.2015.268","article-title":"5-HT1A Autoreceptors in the Dorsal Raphe Nucleus Convey Vulnerability to Compulsive Cocaine Seeking","volume":"41","author":"You","year":"2016","journal-title":"Neuropsychopharmacol"},{"key":"B229","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1111\/j.1476-5381.2009.00521.x","article-title":"Antidepressant-like Effects of Cannabidiol in Mice: Possible Involvement of 5-HT1A Receptors","volume":"159","author":"Zanelati","year":"2010","journal-title":"Br. J. Pharmacol."},{"key":"B230","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1038\/sj.mp.4001560","article-title":"Human Cannabinoid Receptor 1: 5\u2032 Exons, Candidate Regulatory Regions, Polymorphisms, Haplotypes and Association with Polysubstance Abuse","volume":"9","author":"Zhang","year":"2004","journal-title":"Mol. Psychiatry"},{"key":"B231","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19030833","article-title":"Cannabinoid Receptors and the Endocannabinoid System: Signaling and Function in the Central Nervous System","volume":"19","author":"Zou","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"B234","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1177\/0269881108096519","article-title":"Cannabidiol for the Treatment of Psychosis in Parkinson's Disease","volume":"23","author":"Zuardi","year":"2009","journal-title":"J. Psychopharmacol."},{"key":"B233","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1007\/bf02244189","article-title":"Effects of Cannabidiol in Animal Models Predictive of Antipsychotic Activity","volume":"104","author":"Zuardi","year":"1991","journal-title":"Psychopharmacol."},{"key":"B232","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1007\/bf00432554","article-title":"Action of Cannabidiol on the Anxiety and Other Effects Produced by ?9-THC in Normal Subjects","volume":"76","author":"Zuardi","year":"1982","journal-title":"Psychopharmacol."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2021.626010\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,20]],"date-time":"2021-05-20T05:52:16Z","timestamp":1621489936000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2021.626010\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,20]]},"references-count":233,"alternative-id":["10.3389\/fphar.2021.626010"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2021.626010","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,20]]},"article-number":"626010"}}